Human erythroblasts with c-Kit activating mutations have reduced cell culture costs and remain capable of terminal maturation. [electronic resource]
Producer: 20200218Description: 19-24.e4 p. digitalISSN:- 1873-2399
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.